Level
—
Basic safety along with effectiveness of GABAA α5 antagonist S44819 in people together with ischaemic cerebrovascular accident: any multicentre, double-blind, randomised, placebo-controlled trial. https://www.selleckchem.com/products/gdc-0032.html